What is the CVSS score of CVE-2026-21923?

CVE-2026-21923 has a CVSS 3.1 base score of 6.5 (Medium). CVSS vector: CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:L/A:N. EPSS exploitation probability: 0.0%.

Which versions of Life Sciences Central Designer are affected by CVE-2026-21923?

CVE-2026-21923 presents notable security risk rated CVSS 6.5. Exploitation could compromise the security of affected deployments.

How to fix or mitigate CVE-2026-21923?

Within 30 days: Identify affected systems and apply vendor patches as part of regular patch cycle. Monitor vendor channels for patch availability.

Life Sciences Central Designer CVE-2026-21923

MEDIUM

2026-01-20 secalert_us@oracle.com

Oracle Life Sciences Central Designer

6.5

CVSS 3.1 · NVD

Severity by source

NVD PRIMARY

6.5 MEDIUM

AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:L/A:N

Primary rating from NVD · only source for this CVE.

CVSS VectorNVD

CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:L/A:N

Attack Vector

Network

Attack Complexity

Low

Privileges Required

None

User Interaction

None

Scope

Unchanged

Confidentiality

Low

Integrity

Low

Availability

None

Lifecycle Timeline

Analysis Generated

Mar 12, 2026 - 21:54 vuln.today

CVE Published

Jan 20, 2026 - 22:15 nvd

MEDIUM 6.5

DescriptionCVE.org

Vulnerability in the Oracle Life Sciences Central Designer product of Oracle Health Sciences Applications (component: Platform). The supported version that is affected is 7.0.1.0. Easily exploitable vulnerability allows unauthenticated attacker with network access via HTTP to compromise Oracle Life Sciences Central Designer. Successful attacks of this vulnerability can result in unauthorized update, insert or delete access to some of Oracle Life Sciences Central Designer accessible data as well as unauthorized read access to a subset of Oracle Life Sciences Central Designer accessible data. CVSS 3.1 Base Score 6.5 (Confidentiality and Integrity impacts). CVSS Vector: (CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:L/A:N).

AnalysisAI

Life Sciences Central Designer versions up to 7.0.1.0 contains a vulnerability that allows attackers to unauthorized update, insert or delete access to some of Oracle Life Sciences Cen (CVSS 6.5).

Technical ContextAI

affects Life Sciences Central Designer. Vulnerability in the Oracle Life Sciences Central Designer product of Oracle Health Sciences Applications (component: Platform). The supported version that is affected is 7.0.1.0. Easily exploitable vulnerability allows unauthenticated attacker with network access via HTTP to compromise Oracle Life Sciences Central Designer. Successful attacks of this vulnerability can result in unauthorized update, insert or delete access to some of Oracle Life Sciences Central Designer accessible data as w